Skip to main content

Table 1 Major eligibility criteria

From: Study protocol: watchful observation of patients with limited small cell lung cancer instead of the PCI—prospective, multi-center one-arm study

Inclusion criteriaExclusion criteria
Diagnosis of LD-SCLCLack of signed informed consent of the patient
A radical treatment (chemoradiotherapy according to current clinical guidelines) with remission or good/very good response to treatmentDisseminated neoplastic disease
Good general condition of the patient (ECOG/WHO − 0-2)Contraindications for cerebral MRI examination
MRI of the brain in staging before chemoradiation treatmentThe patient is not able to perform tests assessing cognitive functions
Signed informed consentPoor performance status (ECOG/WHO > 2)